Nutritional correlates and dynamics of diabetes in the Nile rat (Arvicanthis niloticus): a novel model for diet-induced type 2 diabetes and the metabolic syndrome.
BACKGROUND
The prevalence of Metabolic Syndrome and related chronic diseases, among them non-insulin-dependent (type 2) diabetes mellitus, are on the rise in the United States and throughout the world. Animal models that respond to environmental stressors, such as diet, are useful for investigating the outcome and development of these related diseases.


OBJECTIVE
Within this context, growth and energy relationships were characterized in the Nile rat, an exotic African rodent, as a potential animal model for diet-induced type 2 diabetes mellitus and Metabolic Syndrome.


METHODS
Compiled data from several studies established the relationship between age, body weight gain (including abdominal adiposity), food and water consumption, and blood glucose levels as determinants of diabetes in male and female Nile rats. Glucose Tolerance Testing, insulin, HbA1c, blood pressure measurements and plasma lipids further characterized the diabetes in relation to criteria of the Metabolic Syndrome, while diet modification with high-fat, low-fiber or food restriction attempted to modulate the disease.


RESULTS
The Nile rat fed lab chow demonstrates signs of the Metabolic Syndrome that evolve into diet-induced non-insulin-dependent (type 2) diabetes mellitus characterized by hyperinsulinemia with rising blood glucose (insulin resistance), abdominal adiposity, and impaired glucose clearance that precedes increased food and water intake, as well as elevated HbA1c, marked elevation in plasma triglycerides and cholesterol, microalbuminuria, and hypertension. Males are more prone than females with rapid progression to diabetes depending on the challenge diet. In males diabetes segregated into early-onset and late-onset groups, the former related to more rapid growth and greater growth efficiency for the calories consumed. Interestingly, no correlation was found between blood glucose and body mass index (overall adiposity) in older male Nile rats in long term studies, whereas blood glucose and the perirenal fat pad, as well as liver and kidney weight, were positively related to early-onset diabetes. Rats weaned early (4-5 wks) and challenged with a high-fat Western-type diet developed diabetes faster, and body fat accumulation was more apparent, whereas food restriction curtailed it.


CONCLUSIONS
The Nile rat fed typical rodent diets develops hyperinsulinemia that precedes hyperglycemia (insulin resistance) leading to diet-induced type 2 diabetes associated with hypertriglyceridemia, hypercholesterolemia, and hypertension. Dietary modulation affected growth rate (weight gain and central adiposity) to impact disease progression. This rodent model represents a novel system of gene-diet interactions affecting energy utilization that can provide insight into the prevention and treatment of the type 2 diabetes and Metabolic Syndrome.
Chaabo
Fadi
F
Foster Biomedical Research Laboratory, Brandeis University, Waltham, MA, USA, 02454. kchayes@brandeis.edu.
Pronczuk
Andrzej
A
Maslova
Ekaterina
E
Hayes
Kc
K
Ann Intern Med. 2000 Aug 1;133(3):176-82
10906831
Hypertension. 2001 Apr;37(4):1053-9
11304502
Heredity (Edinb). 2005 Aug;95(2):158-65
15931239
N Engl J Med. 1996 Mar 21;334(12):777-83
8592553
Diabetes. 1966 Feb;15(2):105-14
5907154
Am J Physiol. 1965 Feb;208:297-300
14259964
Annu Rev Physiol. 2006;68:123-58
16460269
Int J Epidemiol. 2005 Jun;34(3):655-63
15764690
Am J Med. 1976 Jan;60(1):80-8
814810
J Intern Med. 2001 Aug;250(2):105-20
11489060
Endocr Regul. 2002 Mar;36(1):1-8
11971745
Diabetes. 2008 Jun;57(6):1455-6
18511446
Menopause. 2008 May-Jun;15(3):524-9
18467953
Int J Exp Diabetes Res. 2001;2(4):299-319
11795838
Nature. 2001 Dec 13;414(6865):782-7
11742409
ILAR J. 2006;47(3):199-211
16804195
J Pediatr (Rio J). 2007 Nov;83(5 Suppl):S204-8
18038021
J Biol Rhythms. 1999 Oct;14(5):364-77
10511004
J Basic Clin Physiol Pharmacol. 1993 Apr-Jun;4(1-2):57-68
8679511
Circulation. 2003 Sep 30;108(13):1552-3
14517151
Am J Hum Genet. 1962 Dec;14:353-62
13937884
Int J Exp Diabetes Res. 2000;1(3):177-84
11467408
Diabetes Care. 2009 Jan;32 Suppl 1:S13-61
19118286
J Nutr. 1989 Nov;119(11):1726-36
2557406
Diabetes. 1986 Jun;35(6):717-24
3519325
Dig Dis Sci. 2005 Jan;50(1):1-6
15712628
Early Hum Dev. 2009 May;85(5):285-90
19091495
Cell Mol Biol (Noisy-le-grand). 2007 Jul 21;53 Suppl:OL943-53
17666165
Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E510-8
15522998
Metabolism. 1998 Nov;47(11):1354-9
9826212
Cell Metab. 2008 Jan;7(1):45-56
18177724
Cleve Clin J Med. 2008 Oct;75(10):721-8
18939388
BMJ. 1991 Oct 26;303(6809):1019-22
1954451
Cardiovasc Diabetol. 2008 Dec 12;7:35
19077281
Diabetes Care. 2009 Jan;32 Suppl 1:S62-7
19118289
Diabetologia. 2002 Mar;45(3):342-8
11914739
Arch Intern Med. 2008 Jul 28;168(14):1568-75
18663170
Endocrinol Metab Clin North Am. 2004 Jun;33(2):283-303
15158520
Metabolism. 1967 Dec;16(12):1133-9
6065180
Acta Paediatr. 2006 Aug;95(8):904-8
16882560
Circulation. 2003 Sep 23;108(12):1422-4
14504251
Cell Metab. 2008 Feb;7(2):95-6
18249166
Diabetologia. 1996 Sep;39(9):1119-22
8877298
Diabetes Care. 2003 Jan;26 Suppl 1:S5-20
12502614
ILAR J. 2006;47(3):186-98
16804194
BJOG. 2000 Jul;107(7):890-5
10901561
Lab Invest. 1965 Feb;14:200-7
14260252
Diabetologia. 1992 Jul;35(7):595-601
1644236
FASEB J. 2010 Jul;24(7):2443-53
20335226
Hypertension. 1996 Mar;27(3 Pt 2):735-9
8613233